Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2021 and 2022.
-
Legal situation KBO
Opening faillissement according to the CBE.
Financials
Financial year 2022
ALVALUX MEDICAL from Liège, company number BE0642703291, closed financial year 2022 with a result of € -87,900 after tax. For that financial year ALVALUX MEDICAL recorded a gross margin of € 35,740 and equity of € 149,096. Compared with financial year 2021, the result moved from € -173,575 to € -87,900. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 28, 2023.
€ 149,096
▼ 47% vs 2021
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -87,900
▲ 49 % less loss than in 2021
Profit after tax over the fiscal year.
€ 24,656
▼ 68% vs 2021
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -880,771.
People and assets in 2022
1
Average over the fiscal year, from the social balance sheet.
€ 40,850
▲ 11% vs 2021
€ 40,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2022
€ 313,870
▲ 14% vs 2021
€ 13,514 is repaid this year. At this pace the long-term loan is gone in ≈ 20 years.
€ 27,267
▲ 279% vs 2021
Supplier invoices still open on the last day of the fiscal year.
€ 7,625
▲ 14% vs 2021
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | Change 2021 → 2022 | |
|---|---|---|---|
| Gross margin | € -34,437 | € 35,740 | ▲ € 70,177 |
| Profit after taxes | € -173,575 | € -87,900 | ▲ € 85,675 |
| Equity | € 282,273 | € 149,096 | ▼ 47% |
| Total debts | € 703,595 | € 758,482 | ▲ 8% |
| Cash | € 76,070 | € 24,656 | ▼ 68% |
| Retained profit | € -792,870 | € -880,771 | ▼ € 87,900 |
| Bank debt | € 275,000 | € 313,870 | ▲ 14% |
| Balance sheet total | € 985,868 | € 907,578 | ▼ 8% |
| Employees (FTE) | 1 | 1 |
Key figures of ALVALUX MEDICAL, fiscal years 2021 to 2022, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2023 has not been filed yet; it was expected before 31 July 2024.
What happened to ALVALUX MEDICAL?
What happened at ALVALUX MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
ALVALUX MEDICAL is active according to the CBE. Legal situation: Opening faillissement.
- Marc Jacobs stepped down as director. NBB
- Michel Alvarez stepped down as director. NBB
- Christian Bardin stepped down as director. NBB
- New annual accounts for financial year 2022: loss of € 87,900. Source: NBB ↗
- Olivier Ralet stepped down as director. NBB
- Marc Jacobs became a director. NBB
- Christian Bardin became a director. NBB
- Olivier Ralet became a director. NBB
In short
From € 173,575 loss in 2021 to € 87,900 loss in 2022.
On average € 35,700 of value added per employee in 2022.
A new publication or filing at ALVALUX MEDICAL? We notify you, reason included.
Follow ALVALUX MEDICALDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The shares are held by Invest 4 Alvalux (17%). It owns 100% of Cicalux Inc. itself.
Directors
According to the 2022 annual accounts
Christian Bardin
Director
since 2020 · until 2023
Olivier Ralet
Director
since 2020 · until 2022
since 2022 · until 2025
Michel Alvarez
Director
since 2015 · until 2025
Shareholders
17%
Participations
Cicalux Inc.
100%
Establishments
Establishment units
Physical locations of this company
Rue du Palais 8
4000 Liège
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 9 companies are registered at this address.
All companies at this address →LA CIGALIERE
Association des Copropriétaires Résidence Le Palais à Liège rue du Palais 8
WEB-IMMOCOACH
€ 47,143 gross margin · 2023
SNB Partners
€ -76 gross margin · 2024
CREPI STONE CONSTRUCT
€ 8,330 gross margin · 2025
+4 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0642.703.291
- VAT number
- BE 0642.703.291
- Registered office
- Rue du Palais 8, 4000 Liège
- Names & denominations
- ALVALUX MEDICAL
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Opening faillissement
- Start date
- 6 November 2015
- Peppol
- Not registered
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overige financiële dienstverlening, neg
Overige ondersteunende activiteiten in verband met financiële diensten, neg, exclusief verzekeringen en pensioenfondsen
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied